MSD has announced interim results of a trial involving anti-PD-1 antibody KEYTRUDA (pembrolizumab) for the treatment of bladder cancer. …
Latest Video
New Stories
-
Push to end the lung cancer​ stigma as government announces new listing
January 21, 2019 - - Latest News -
Greg Hunt pushes sector on CMI access
January 21, 2019 - - Latest News -
No easy solution to fill MA vacancies
January 21, 2019 - - Latest News -
Department delays further discussion on payment reform
January 21, 2019 - - Latest News -
Who is ready for RCA's 'P2P Cycle Challenge'?
January 21, 2019 - - Latest News -
A relationship that works for patients
January 18, 2019 - - Comment -
Pharmaxis updates on LOXL2 studies
January 18, 2019 - - Latest News